These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19188169)

  • 21. TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer.
    Erber R; Conradt C; Homann N; Enders C; Finckh M; Dietz A; Weidauer H; Bosch FX
    Oncogene; 1998 Apr; 16(13):1671-9. PubMed ID: 9582015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients.
    van Zeeburg HJ; Snijders PJ; Pals G; Hermsen MA; Rooimans MA; Bagby G; Soulier J; Gluckman E; Wennerberg J; Leemans CR; Joenje H; Brakenhoff RH
    Cancer Res; 2005 Feb; 65(4):1271-6. PubMed ID: 15735012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of tumor suppressor p53 status in head and neck squamous cell carcinoma.
    Smardova J; Ksicova K; Binkova H; Krpensky A; Pavlova S; Rottenberg J; Koukalova H
    Oncol Rep; 2004 Apr; 11(4):923-9. PubMed ID: 15010896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High level of aneuploidy of chromosome 6 by FISH analysis of head and neck squamous cell carcinoma: limited applicability of LOH analysis to define HLA loss.
    Koene GJ; Arts-Hilkes YH; van Dijk AJ; van der Ven KJ; Slootweg PJ; de Weger RA; Tilanus MG
    Hum Immunol; 2004 Dec; 65(12):1455-62. PubMed ID: 15603873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival after surgical resection of pulmonary metastases and second primary squamous cell lung carcinomas in head and neck cancer.
    Geurts TW; Balm AJ; van Velthuysen ML; van Tinteren H; Burgers JA; van Zandwijk N; Klomp HM
    Head Neck; 2009 Feb; 31(2):220-6. PubMed ID: 18972427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
    Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic alteration in carcinoid tumors of the lung.
    Sugio K; Osaki T; Oyama T; Takenoyama M; Hanagiri T; Morita M; Yamazaki K; Nagashima A; Nakahashi H; Maehara Y; Yasumoto K
    Ann Thorac Cardiovasc Surg; 2003 Jun; 9(3):149-54. PubMed ID: 12875635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular discrimination of multiple primary versus metastatic squamous cell cancers of the head/neck and lung.
    Mercer RR; Lucas NC; Simmons AN; Zander DS; Tsongalis GJ; Funkhouser WK; Coleman WB
    Exp Mol Pathol; 2009 Feb; 86(1):1-9. PubMed ID: 19094981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical applications of the diagnosis of p53 alterations in squamous cell carcinoma of the head and neck.
    Lopez-Martinez M; Anzola M; Cuevas N; Aguirre JM; De-Pancorbo M
    Med Oral; 2002; 7(2):108-20. PubMed ID: 11887018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The possible role of TP53 mutation status in the treatment of squamous cell carcinomas of the head and neck (HNSCC) with radiotherapy with different overall treatment times.
    Eriksen JG; Alsner J; Steiniche T; Overgaard J
    Radiother Oncol; 2005 Aug; 76(2):135-42. PubMed ID: 16024113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
    Gradowski JF; Mantha GS; Hunt JL; Dacic S
    Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV status.
    Fallai C; Perrone F; Licitra L; Pilotti S; Locati L; Bossi P; Orlandi E; Palazzi M; Olmi P
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1053-9. PubMed ID: 19577857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correspondence re: F. Coulet et al., Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis. Cancer Res., 60: 707-709, 2000.
    Silva JM; Bonilla F
    Cancer Res; 2001 Dec; 61(23):8595-6. PubMed ID: 11731447
    [No Abstract]   [Full Text] [Related]  

  • 34. Longitudinal study of TP53 mutations in eight patients with potentially malignant oral mucosal disorders.
    Ogmundsdóttir HM; Hilmarsdóttir H; Björnsson J; Holbrook WP
    J Oral Pathol Med; 2009 Oct; 38(9):716-21. PubMed ID: 19473449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular analysis of synchronous and metachronous tumors of the lung: impact on management and prognosis.
    Huang J; Behrens C; Wistuba I; Gazdar AF; Jagirdar J
    Ann Diagn Pathol; 2001 Dec; 5(6):321-9. PubMed ID: 11745069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent chromosome Y loss in primary, second primary and metastatic squamous cell carcinomas of the head and neck region.
    Kujawski M; Jarmuz M; Rydzanicz M; Szukala K; Wierzbicka M; Grenman R; Golusinski W; Szyfter K
    Cancer Lett; 2004 May; 208(1):95-101. PubMed ID: 15105051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck.
    Farhadieh RD; Smee R; Rees CG; Salardini A; Eggleton S; Yang JL; Russell PJ
    ANZ J Surg; 2009; 79(1-2):48-54. PubMed ID: 19183379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
    Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TP53 mutations in head and neck cancer.
    Beutner D; Klussmann JP; Guntinas-Lichius O
    N Engl J Med; 2008 Mar; 358(11):1194; author reply 1195. PubMed ID: 18337610
    [No Abstract]   [Full Text] [Related]  

  • 40. Loss of heterozygosity, microsatellite instability and TP53 gene status in ovarian carcinomas.
    Plisiecka-Hałasa J; Dansonka-Mieszkowska A; Kraszewska E; Dańska-Bidzińska A; Kupryjańczyk J
    Anticancer Res; 2008; 28(2A):989-96. PubMed ID: 18507046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.